Insider Transactions in Q3 2023 at Altimmune, Inc. (ALT)
Insider Transaction List (Q3 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Aug 15
2023
|
David Drutz Director |
BUY
Open market or private purchase
|
Indirect |
300
+1.0%
|
$600
$2.88 P/Share
|
|
Jul 31
2023
|
Matthew Scott Harris Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
691
+1.99%
|
$1,382
$2.81 P/Share
|
|
Jul 31
2023
|
Richard I Eisenstadt Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
1,825
+7.11%
|
$3,650
$2.81 P/Share
|
|
Jul 31
2023
|
Vipin K Garg President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
126
+0.05%
|
$252
$2.81 P/Share
|
|
Jul 31
2023
|
M Scot Roberts Chief Scientific Officer |
BUY
Grant, award, or other acquisition
|
Direct |
568
+2.71%
|
$1,136
$2.81 P/Share
|
|
Jul 31
2023
|
Raymond M Jordt Chief Business Officer |
BUY
Grant, award, or other acquisition
|
Direct |
1,832
+50.0%
|
$3,664
$2.81 P/Share
|